Who has invested in Onconano Medicine?

CPRIT are named among the investors backing Onconano Medicine.

Onconano Medicine Funding: $68M Raised, Series B (2021)

Onconano Medicine funding overview

Onconano Medicine is based in Southlake. Onconano Medicine has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2021. The round record for Onconano Medicine runs through 2021; nothing later has been disclosed. Investors on record include CPRIT.

Onconano Medicine at a glance

Total raised: $68M
Latest round: Series B
Latest round date: October 2021
Headquarters: Southlake
Notable investors: CPRIT

Frequently asked about Onconano Medicine funding

How much has Onconano Medicine raised?: Onconano Medicine has raised $68M in total disclosed funding across the rounds on record.
Who has invested in Onconano Medicine?: CPRIT are named among the investors backing Onconano Medicine.
What was the latest Onconano Medicine funding round?: The most recent disclosed round is a Series B, announced in October 2021.
Where is Onconano Medicine based?: Onconano Medicine is based in Southlake.
When did Onconano Medicine last raise?: The last disclosed Onconano Medicine round closed in October 2021 at Series B.

Totals shown for Onconano Medicine aggregate every disclosed round on file. To see how that compares, browse the companies in Southlake and the investors behind them below.

Onconano Medicine Funding: $68M Raised, Series B (2021)

Onconano Medicine funding overview

Onconano Medicine at a glance

Frequently asked about Onconano Medicine funding

Companies related to Onconano Medicine (34)

Browse related funding lists (3)